Peptide carrier for drug delivery

Details Peptide carrier for drug delivery Peptide carrier for drug delivery

2006-09-01

2008-09-30

Carlson, Karen Cochrane (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S300000, C530S350000

Reexamination Certificate

active

07429563

ABSTRACT:
The present invention is directed to compositions based on myeloperoxidase amino acid sequence which may be used as therapeutic agents or as delivery vehicles for the delivery of other therapeutic agents.

REFERENCES:
patent: 4018884 (1977-04-01), Cleeland, Jr. et al.
patent: 4744981 (1988-05-01), Pavanasasivam
patent: 4897255 (1990-01-01), Fritzberg et al.
patent: 4988496 (1991-01-01), Srinivasan et al.
patent: 5106951 (1992-04-01), Morgan, Jr. et al.
patent: 5460961 (1995-10-01), Deby et al.
patent: 5493007 (1996-02-01), Burnier et al.
patent: 5708009 (1998-01-01), Glasebrook
patent: 5708010 (1998-01-01), Glasebrook
patent: 5981194 (1999-11-01), Jefferies et al.
patent: 5985272 (1999-11-01), Deby et al.
patent: 6172043 (2001-01-01), Ingram et al.
patent: 0 367 566 (1990-05-01), None
patent: WO 91/18982 (1991-12-01), None
patent: WO98/07848 (1998-02-01), None
patent: WO-9807848 (1998-02-01), None
patent: WO 01/59459 (2001-08-01), None
patent: WO 02/13843 (2002-02-01), None
Hashinaka et al. 1988; Biochemistry 27: 5906-5914.
Abu-Soud et al., Nitric oxide is a physiological substrate for mammalian peroxidases, J. Biol. Chem., 275:37524-37532, 2000.
Agner, Verdoperoxidase, Acta Physiol. Scand., 2(suppl 8):5-62, 1941.
Andersson et al., Large-scale synthesis of peptides, Biopolymers Pept. Sci., 55:227-250, 2000.
Andersson et al., The role of the propeptide for processing and sorting of human myeloperoxidase, J. Biol. Chem., 273:4747-4753, 1988.
Anwer et al., Backbone modifications in cyclic peptides. Conformational analysis of a cyclic pseudopentapeptide containing a thiomethylene ether amide bond replacement, Int. J. Pept. Protein Res., 36:392-399, 1990.
Baldus et al., Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes, Circulation, 108:1440-1445, 2003.
Barany et al., Solid phase peptide synthesis (chapter 1), The Peptides: Anaysis, Synthesis, Biology, edited by Gross et al., Academic Press, 2:1-284, 1979.
Blair et al., Linkage of cytotoxic agents to immunoglobulins, J. Immunol. Methods, 59:129-143, 1983.
Blättler et al., New heterobifunctional protein crosslinking reagent that forms an acid-labile link, Biochem., 24:1517-1524, 1985.
Brennan et al., A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species, J. Biol. Chem., 277:17415-17427, 2002.
Brennan et al., Prognostic value of myeloperoxidase in patients with chest pain, N. Eng. J. Med., 349:1595-1604, 2003.
Bundgaard, Vesicular transport in capillary endothelium: does it occur?, Faseb J., 42:2425-2430, 1983.
Burgess et al., DiSSiMiL: diverse small size mini-libraries applied to simple and rapid epitope mapping of a monoclonal antibody, J. Pept. Res., 57:68-76, 2001.
Carver et al., Caveolae: mining little caves for new cancer targets, Nat. Rev. Cancer, 3:571-581, 2003.
Cosman et al., Cloning, sequence and expression of human interleukin-2 receptor, Nature, 312:768-771, 1984.
Cosman et al., High level stable expression of human interleukin-2 receptors in mouse cells generates only low affinity interleukin-2 binding sites, Mol. Immunol., 23:935-941, 1986.
Daugherty et al., Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions, J. Clin. Invest., 94:437-444, 1994.
Dvorak et al., Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies, Cancer Cells, 3:77-85, 1991.
Engelhard et al., The insect tracheal system: a conduit for the systemic spread ofAutographa californicaM nuclear polyhedrosis virus, PNAS USA, 91:3224-3227, 1994.
Fields, Peptides for the New Millennium, edited by Tam et al., Kluwer Academic Publisher, Dordrecht, 2000.
Fields, Solid-Phase Peptide Synthesis. Academic Press, San Diego, 1997.
GenBank Accession No. AAR99349, Myeloperoxidase precursor [Mus musculus], Mar. 1, 2005.
GenBank Accession No. AY500847, Myeloperoxidase precursor [Mus musculus], mRNA, complete cds, Mar. 1, 2005.
GenBank Accession No. NM13000250, Myeloperoxidase [Homo sapiens], nuclear gene encoding mitochondrial protein, mRNA, Sep. 17, 2007.
GenBank Accession No. NM—010824, Myeloperoxidase [Mus musculus], mRNA, Sep. 3, 2007.
GenBank Accession No. NP—000241, Myeloperoxidase [Homo sapiens], Sep. 17, 2007.
GenBank Accession No. NP—034954, Myeloperoxidase [Mus musculus], Sep. 3, 2007.
GenBank Accession No. P05164, Myeloperoxidase precursor (MPO) [Contains: 89 kDa myeloperoxidase;84 kDa myeloperoxidase; myeloperoxidase light chain; myeloperoxidase heavy chain], Jul. 10, 2007.
Greenwald et al., Poly(ethylene glycol) conjugated drugs and prodrugs: a comprehensive review, Crit. Rev. Ther. Drug Carrier Syst., 17:101-161, 2000.
Harris et al., Pegylation: a novel process for modifying pharmacokinetics, Clin. Pharmacokinet., 40:539-551, 2001.
Hermanson, Bioconjugate Techniques, Academic Press, 1996.
Inman, Convalent linkage of functional groups, ligands, and proteins to polyacrylamide beads, Methods in Enzymology, Affinity Techniques, Enzyme Purification: Part B, edited by Jakoby et al., Academic Press, New York, 34:30-58, 1974.
Jain, The next frontier of molecular medicine: delivery of therapeutics, Nat. Med., 4:655-657, 1998.
Jansson, Oestrogen-induced enhancement of myeloperoxidase activity in human PMN leukocytes; a possible cause of oxidative stress in inflammatory cells, Free Rad. Res. Commun., 143:195-208, 1991.
John et al., Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer, Am. J. Physiol Lung Cell. Mol. Physiol., 284:L187-L196, 2003.
Karas et al., Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons, Anal, Chem., 60:2299-2301, 1988.
King et al., Preparation of protein conjugates via intermolecular hydrazone linkage, Biochem., 25:5774-5779, 1986.
Kopecek et al., Water soluble polymers in tumor targeted delivery, J. Controlled Release., 74:147-158, 2001.
Lamb et al., Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome; evidence for neutrophil-mediated hydroxylation, nitration, and chlorination, Crit. Care Med., 27:1738-1744, 1999.
Leeuwenburgh et al., Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima, J. Biol. Chem., 272:1433-1436, 1997.
McIntosh et al., Caveolae require intact VAMP for targeted transport in vascular endothelium, Am. J. Physiol., 277:H2222-H2232, 1999.
McIntosh et al., Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery, PNAS USA 994:1996-2001, 2002.
Merrifield, Solid phase synthesis, Science, 232:341-347, 1986.
Miller et al., Targeted vectors for gene therapy, FASEB J., 9:190-199, 1995.
Minshall et al., Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway, J. Biol. Chem., 150:1057-1069, 2000.
Nachman et al., Pseudodipeptide analogs of the pyrokinin/PBAN (FXPRLa) insect neuropeptide family containing carbocyclic Pro-mimetic conformational components, Regul. Pept., 57:359-370, 1995.
Nathan et al., Copolymers of lysine and polyethylene glycol: a new family of functionalized drug carriers, Bioconj. Chem., 4:54-62, 1993.
Nathan et al., Hydrogels based on water-soluble poly(ether urethanes) derived from L-lysine and poly(ethylene glycol), Macromolecules, 25:4476-4484, 1992.
Oh et al., Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium, J. Biol. Chem., 141:101-114, 1998.
Okayama et al., A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells, Mol. Cell. Biol., 3:280-289, 1983.
Renkin, Capillary transport of macromolecules: pores and other endothelial pathways, J. Appl. Physiol., 58:315-325, 1985.
Retnoningrum et al., M12 protein fromStreptococcus pyoge

Affiliated with

Also associated with

Rating

Peptide carrier for drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide carrier for drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide carrier for drug delivery will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3980773